0001739074-21-000004.txt : 20210225
0001739074-21-000004.hdr.sgml : 20210225
20210225160647
ACCESSION NUMBER: 0001739074-21-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210225
DATE AS OF CHANGE: 20210225
EFFECTIVENESS DATE: 20210225
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001831828
IRS NUMBER: 812744449
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-390559
FILM NUMBER: 21680280
BUSINESS ADDRESS:
STREET 1: 170 HARBOR WAY
STREET 2: 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-770-0077
MAIL ADDRESS:
STREET 1: 170 HARBOR WAY
STREET 2: 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
D
1
primary_doc.xml
X0708
D
LIVE
0001831828
Vera Therapeutics, Inc.
170 HARBOR WAY
3RD FLOOR
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
650-770-0077
DELAWARE
CDF Therapeutics, Inc.
Trucode Gene Repair, Inc.
None
Corporation
true
2016
Marshall
Fordyce
170 Harbor Way
3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Andrew
Cheng
170 Harbor Way
3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Scott
Morrison
170 Harbor Way
3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Beth
Seidenberg
170 Harbor Way
3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Patrick
Enright
170 Harbor Way
3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Maha
Katabi
170 Harbor Way
3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Kurt
von Emster
170 Harbor Way
3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-10-29
false
true
false
0
70736334
70736334
0
Includes $5,736,335.77 in cancelled convertible debt and does not include $28,121,124.59 sold to two investors who reside outside the United States.
false
23
0
0
0
false
Vera Therapeutics, Inc.
/s/ Marshall Fordyce
Marshall Fordyce
Chief Executive Officer
2021-02-17